Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Radius Residential CareNZSE:RAD +3.53%47 3-Year EBITDA Growth Rate is 15.90% as of Mar. 2026, which is 112% above its 10-year median of 7.50. GuruFocus rates NZSE:RAD with a GF Score™ of 47/100 and a GF Value™ of NZ$0.29 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Radius Residential Care ranks better than 60% on this metric.
During the past 12 months, Radius Residential Care's average EBITDA Per Share Growth Rate was 14.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 15.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 5.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Radius Residential Care was 15.90% per year. The lowest was -1.00% per year. And the median was 7.50% per year.
Radius Residential Care (NZSE:RAD) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Radius Residential Care 3-Year EBITDA Growth Rate Related Terms
NZSE:RAD vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Radius Residential Care's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Radius Residential Care 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Radius Residential Care's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Radius Residential Care's 3-Year EBITDA Growth Rate falls into.
Radius Residential Care 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 15.90% mean?
Radius Residential Care (NZSE:RAD) has a 3-Year EBITDA Growth Rate of 15.90% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Radius Residential Care and its competitors. This is 112% above median its historical median of 7.50. According to the industry distribution chart, Radius Residential Care ranks #210 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 40%.
Is Radius Residential Care's 3-Year EBITDA Growth Rate too high?
Radius Residential Care's current 3-Year EBITDA Growth Rate of 15.90% is 112% above median its 10-year median of 7.50. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. Radius Residential Care's value of 15.90% is 60.6% above this industry median. Based on the distribution chart, Radius Residential Care ranks #210 out of 525 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Radius Residential Care has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Radius Residential Care's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Radius Residential Care ranks #210 out of 525 companies for 3-Year EBITDA Growth Rate. This puts Radius Residential Care in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. Radius Residential Care's value of 15.90% is 60.6% above this benchmark. While the company's 10-year median is 7.50 vs. the industry median of 9.90, Radius Residential Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Radius Residential Care's current 3-Year EBITDA Growth Rate of 15.90% is 60.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Radius Residential Care and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Radius Residential Care's current 3-Year EBITDA Growth Rate is 15.90%, which is 112% above median its own 10-year median of 7.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radius Residential Care stock overvalued right now?
Based on GuruFocus' analysis, Radius Residential Care (NZSE:RAD) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.29, compared to a current price of NZ$0.44 — trading 51.7% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 15.90%, which is 112% above median its 10-year median of 7.50 and 60.6% above the Healthcare Providers & Services industry median of 9.90. Radius Residential Care's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Radius Residential Care (NZSE:RAD), the current 3-Year EBITDA Growth Rate is 15.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Radius Residential Care (NZSE:RAD) Overvalued in 2026?
Based on GuruFocus' analysis, Radius Residential Care stock appears to be overvalued.
The current stock price of NZ$0.44 is trading 51.7% above its estimated GF Value™ of NZ$0.29.
GuruFocus considers Radius Residential Care to be Significantly Overvalued.
Key valuation signals for NZSE:RAD:
3-Year EBITDA Growth Rate: 15.90% (112% above median its 10-year median of 7.50)
GF Value™: NZ$0.29 vs. price of NZ$0.44 (51.7% above fair value)
Industry Position: 60.6% above the Healthcare Providers & Services median (#210 of 525)
No single metric tells the full story. See the NZSE:RAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Radius Residential Care Ltd is a health and aged care provider for elderly and disabled people. The company provides residential care, hospital care, dementia care, respite care, and palliative care. Additionally, the company offers Young Disabled Care services for those under 65 who require assistance with self-care, mobility, and/or communication. It has one operating segment, being the provision of aged care in New Zealand.
47GF Score
Get the complete analysis for NZSE:RAD
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:RAD has been successfully added to your 
